Organ Donation and Transplantation World-wide: The Global Observatory on Donation and Transplantation Annual Report
The Global Observatory on Donation and Transplantation (GODT), an initiative of the World Health Organization (WHO) in collaboration with the Organización Nacional de Trasplantes (ONT, Spain), collects data and reports on the donation and transplantation activity of WHO member states. GODT is the only registry providing world-wide transplant data.
This unique global report on organ donation, transplantation and waitlisting presented by authors from ONT, WHO, Council of Europe, Berlin and Boston includes activities from 92 countries in 2024 detailing global, regional, and country-specific perspectives.
Global Strategies for Advancing Diversity, Equity, and Inclusion in Transplantation: Insights from the Inaugural International Congress
This manuscript provides a summary and recommendations of an International Congress on Diversity, Equity & Inclusion. This meeting brought together transplant professionals and patients addressing key challenges around gender & racial disparities, wellness & balance, self-advocacy & mentorship and equity to transplantation for both pediatric and adults’ recipients. Those proceedings provide a call to action to critically examine existing structures and implement solutions.
Age-Stratified Data Highlights Worldwide Variability in Organ Donation Rates and the Potential Increase in Organ Donation
High-quality data from 17 countries across three continents are presented in this work, comparing age-stratified organ donation metrics. Key findings include i), large differences in age-stratified donation rates, ii), a country-specific potential for growth, and iii), country-specific donor rates by age.
These results hold the potential to change where the US and peer countries invest resources in promoting organ donation.
Improved DCD Heart Transplant Function through Ferroptosis Blockade in a Model of Experimental Normothermic Ex Vivo Perfusion
Normothermic ex-vivo organ perfusion has been key in facilitating the successful utilization of organs from donors after circulatory death. This experimental study demonstrates that normothermic ex vivo heart perfusion combined with Liproxstatin-1, a selective ferroptosis inhibitor may represent a novel preservation strategy, alleviating cardiac ischemia-reperfusion injury via inhibiting myocardial ferroptosis.